General Information of Drug (ID: DMG21PZ)

Drug Name
Di(2,6-diisopropylphenol) Drug Info
Synonyms
3,3',5,5'-Tetraisopropylbiphenyl-4,4'-diol; 2416-95-7; Dipropofo; UNII-H9GE6HX42A; di(2,6-diisopropylphenol); H9GE6HX42A; CHEMBL478518; 3,3',5,5'-Tetrakis(1-methylethyl)biphenyl-4,4'-diol; AK-51092; 3,3',5,5'-Tetraisopropyl-[1,1'-biphenyl]-4,4'-diol; Propofol related compound A; Dipropofol; Propofol related compound A [USP]; Propofol specified impurity E [EP]; Propofol Impurity E; Propofol related compound A RS [USP]; 3,3',5,5'-Tetraisopropyl-4,4'-dihydroxybiphenyl; SCHEMBL275427; CTK4F3066; DTXSID30178867
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
11602828
CAS Number
CAS 2416-95-7
TTD Drug ID
DMG21PZ

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Carbonic anhydrase II (CA-II) TTANPDJ CAH2_HUMAN Inhibitor [1]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Carbonic anhydrase II (CA-II) DTT CA2 8.796 10.933 9.395 9.819
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Carbonic anhydrase II (CA-II) DTT CA2 7.95E-08 0.52 0.33
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols. Bioorg Med Chem. 2009 Apr 15;17(8):3207-11.